Michele Tana, MD, MHS
Associate Professor
Medicine
School of Medicine

She was a Hepatology Fellow at the National Institutes of Health in the National Institute of Diabetes and Digestive and Kidney Diseases and earned a Masters Degree in Clinical Research from Duke University. Dr. Tana joined the UCSF faculty in 2013. She serves the vulnerable patient population at Zuckerberg San Francisco General Hospital and teaches UCSF students and trainees. She directs the Gastroenterology Rotation for Surgery Residents and serves as a Hepatitis C Consultant for the National Clinician Consultation Center. In 2018, she helped launch Prospective Observational Study to Understand Liver Diseases (POSULD). Her team collaborates with researchers across disciplines and across the globe to apply state-of-the-art science and technology to liver diseases, with a focus on health equity in autoimmune hepatitis.

• Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
  PloS one 2022 Tana MM, Klepper A, Lyden A, Pisco AO, Phelps M, McGee B, Green K, Feng S, DeRisi J, Crawford ED, Lammert CS
• Outcomes of pregnancy in autoimmune hepatitis: A population-based study.
  Hepatology (Baltimore, Md.) 2021 Wang CW, Grab J, Tana MM, Irani RA, Sarkar M
• Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2021 Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S
• Thinking Ahead: Advance Care Planning for Patients With Cirrhosis.
  Clinical liver disease 2021 Deng LX, Tana MM, Lai JC
• We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases.
  Hepatology (Baltimore, Md.) 2021 Lee BT, Tana MM, Kahn JA, Dara L
• Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response.
  Hepatology communications 2021 Gara N, Tana MM, Kattapuram M, Auh S, Sullivan L, Fryzek N, Walter M, Umarova R, Zhao X, Cloherty G, Doo E, Heller T, Liang TJ, Ghany MG
• Texture features from computed tomography correlate with markers of severity in acute alcohol-associated hepatitis.
  Scientific reports 2020 Tana MM, McCoy D, Lee B, Patel R, Lin J, Ohliger MA
• Obesity and metabolic outcomes in a safety-net health system.
  Biodemography and social biology 2020 Huynh MP, Bradshaw PT, Tana MM, Rachocki C, Somsouk M
• Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S
• Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
  Digestive diseases and sciences 2019 Galoosian A, Hanlon C, Tana M, Cheung R, Wong RJ
• The Spectrum of Hepatic Involvement in Patients With Telomere Disease.
  Hepatology (Baltimore, Md.) 2019 Kapuria D, Ben-Yakov G, Ortolano R, Cho MH, Kalchiem-Dekel O, Takyar V, Lingala S, Gara N, Tana M, Kim YJ, Kleiner DE, Young NS, Townsley DM, Koh C, Heller T
• Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved.
  Autoimmunity 2018 Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM
• Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.
  The American journal of gastroenterology 2018 Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM
• Imaging Manifestations of Peptic Ulcer Disease on Computed Tomography.
  Seminars in ultrasound, CT, and MR 2017 Baghdanian AH, Baghdanian AA, Puppala S, Tana M, Ohliger MA
• Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms
  Fatigue: Biomedicine, Health & Behavior. 2017 Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y
• Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms.
  Fatigue : biomedicine, health & behavior 2017 Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Rehman RB, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y
• Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?
  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2017 Tana MM, Muir AJ
• A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase.
  Clinica chimica acta; international journal of clinical chemistry 2016 van Wijk XMR, Magee CA, Wu AHB, Tana MM, Lynch KL
• Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
  Cancer 2016 Ha J, Yan M, Aguilar M, Bhuket T, Tana MM, Liu B, Gish RG, Wong RJ
• Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
  Journal of clinical gastroenterology 2016 Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ
• The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.
  American journal of clinical pathology 2015 Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH
• Factors associated with the platelet count in patients with chronic hepatitis C.
  Thrombosis research 2015 Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T
• Autoantibodies in hepatitis C: red flag or bystander effect?
  Journal of pediatric gastroenterology and nutrition 2013 Tana MM, Heller T
• Hepatitis B virus treatment: Management of antiviral drug resistance.
  Clinical liver disease 2013 Tana MM, Ghany MG
• Scar undone: long-term therapy of hepatitis B.
  Lancet (London, England) 2012 Tana MM, Hoofnagle JH